Gemma Wynd
Research Subjects
Gemma Wynd has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Carla Morris
2 shared publications- Dimitri Gerostamoulos
Victorian Institute of Forensic Medicine, Southbank
2 shared publications - Linda Glowacki
Victorian Institute of Forensic Medicine, Southbank
2 shared publications Matthew Di Rago
2 shared publicationsNoel W. Woodford
2 shared publications- Olaf Heino Drummer
Department of Forensic Medicine, Monash University, Melbourne, Victoria, Australia
2 shared publications
Latest Publications
- 26 October 2026
- Published by Elsevier in Accident Analysis & Prevention
- Vol. 239
Odds of culpability associated with the presence of drugs in injured drivers
- 26 October 2026
- Published by Elsevier in Accident Analysis & Prevention
- Vol. 239
Odds of culpability associated with the presence of drugs in injured drivers
- Open Access
- 6 April 2026
- Published by Elsevier in SSRN Electronic Journal
Estimates of crash risk associated with the presence of drugs in injured drivers
Responsibility analysis was conducted on almost 10,000 drivers injured over a 10-year period in Victoria as a result of a vehicular collision and in whom comprehensive toxicology testing in blood was conducted. Multivariable logistic regression models were fitted to compute unadjusted (OR) and adjusted odds ratios (aOR). In the multivariable model, adjustments were made for gender, age group, vehicle type, and whether the crash occurred in metropolitan or rural areas. The psychoactive drug-free driver was the reference group. Drivers with ethanol (alcohol) present at any concentration (>0.01% BAC) confirmed the well-known large increases in crash risk that occur with rising blood ethanol concentration, with an aOR of 16.4 (95%CI 11.1–24.2). Drivers positive to methamphetamine and no other psychoactive drug also showed a large increase in the odds of culpability (aOR 17.2, 95%CI 10.2-29.2). Drivers with Δ9-tetrahydrocannabinol (THC) in blood showed a modest increase in odds when all concentrations (> 1ng/mL) were assessed (aOR 1.5, 95%CI 1.1-2.0) that increased to an aOR 2.1 (95%CI 0.9-4.9) when concentrations were 10 ng/mL or higher. Benzodiazepines in drivers also showed a significant increase in odds (aOR1.8, 95%CI 1.2-2.8), as well as antidepressants (aOR 1.3, 95%CI 1.0-1.6). Opioids such as codeine and oxycodone showed no measurable increase in crash risk, whereas combinations of ethanol with methamphetamine or THC gave aOR of 22.6 (95%CI 3.0-168) and 20.0 (95%CI 7.3-54.5), respectively, as well as drivers positive to both THC and methamphetamine (aOR 14.6, 95% CI 5.9-36.4). Drivers positive to one or more illicit drug, or a larger selection of psychoactive drugs in the absence of ethanol both gave similarly large increase in odds (aOR 4.0, 95%CI 3.3-5.0). This study contributes to a better understanding of risks associated with driving in the presence of common psychoactive drugs.
- 6 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEstimates of crash risk associated with the presence of drugs in injured drivers
Responsibility analysis was conducted on almost 10,000 drivers injured over a 10-year period in Victoria as a result of a vehicular collision and in whom comprehensive toxicology testing in blood was conducted. Multivariable logistic regression models were fitted to compute unadjusted (OR) and adjusted odds ratios (aOR). In the multivariable model, adjustments were made for gender, age group, vehicle type, and whether the crash occurred in metropolitan or rural areas. The psychoactive drug-free driver was the reference group. Drivers with ethanol (alcohol) present at any concentration (>0.01% BAC) confirmed the well-known large increases in crash risk that occur with rising blood ethanol concentration, with an aOR of 16.4 (95%CI 11.1–24.2). Drivers positive to methamphetamine and no other psychoactive drug also showed a large increase in the odds of culpability (aOR 17.2, 95%CI 10.2-29.2). Drivers with Δ9-tetrahydrocannabinol (THC) in blood showed a modest increase in odds when all concentrations (> 1ng/mL) were assessed (aOR 1.5, 95%CI 1.1-2.0) that increased to an aOR 2.1 (95%CI 0.9-4.9) when concentrations were 10 ng/mL or higher. Benzodiazepines in drivers also showed a significant increase in odds (aOR1.8, 95%CI 1.2-2.8), as well as antidepressants (aOR 1.3, 95%CI 1.0-1.6). Opioids such as codeine and oxycodone showed no measurable increase in crash risk, whereas combinations of ethanol with methamphetamine or THC gave aOR of 22.6 (95%CI 3.0-168) and 20.0 (95%CI 7.3-54.5), respectively, as well as drivers positive to both THC and methamphetamine (aOR 14.6, 95% CI 5.9-36.4). Drivers positive to one or more illicit drug, or a larger selection of psychoactive drugs in the absence of ethanol both gave similarly large increase in odds (aOR 4.0, 95%CI 3.3-5.0). This study contributes to a better understanding of risks associated with driving in the presence of common psychoactive drugs.